C, A., L, A., M, P., JM, F., CJ, C., IG, S., . . . I, B. (2024). Multimodal Fusion Artificial Intelligence Model to Predict Risk for MACE and Myocarditis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy. JACC. Advances, 4(1), 101435. https://doi.org/10.1016/j.jacadv.2024.101435
Chicago Style (17th ed.) CitationC, Ayoub, et al. "Multimodal Fusion Artificial Intelligence Model to Predict Risk for MACE and Myocarditis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy." JACC. Advances 4, no. 1 (2024): 101435. https://doi.org/10.1016/j.jacadv.2024.101435.
MLA (9th ed.) CitationC, Ayoub, et al. "Multimodal Fusion Artificial Intelligence Model to Predict Risk for MACE and Myocarditis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy." JACC. Advances, vol. 4, no. 1, 2024, p. 101435, https://doi.org/10.1016/j.jacadv.2024.101435.